CoChat

Quality of life of patients with irritable bowel syndrome is low compared to others with chronic diseases

ten Berg, Maarten J., Goettsch, Wim G., van den Boom, Guido, Smout, Andr?? J.P.M., Herings, Ron M.C. · 2006 · European Journal of Gastroenterology & Hepatology

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Irritable bowel syndrome (IBS) is a prevalent functional gastrointestinal dysmotility disorder. This study aimed to estimate the burden of illness of a Dutch population of community dwelling patients suffering from IBS. METHODS: Patients identified at community pharmacies, using mebeverine as a proxy for IBS, were administered a questionnaire regarding (1) the Rome II criteria for IBS, (2) predominant type of stool during complaints, (3) severity of symptoms (abdominal pain and discomfort), (4) generic and disease-specific quality of life, (5) current health status (utilities), and (6) loss of productivity. RESULTS: Three hundred and seventy-five users of mebeverine were identified of which 169 patients met the Rome II criteria for IBS, and were included in the study. More than half (58%) of the IBS patients reported severe abdominal pain and complaints. Generic and disease-specific quality of life outcomes showed impairment on all dimensions. Current health status in IBS patients, calculated on the basis of the EQ-5D VAS, was perceived on 62% of full health (95% CI, 60-66%). A calculation of health status in these patients based on the SF-6D algorithm showed a comparable score of 0.67 (1 is full health; 95% CI, 0.65-0.68). The loss in productivity of IBS patients was 1.8 days (95% CI, 1.1-2.5) per month. CONCLUSIONS: This study confirmed that the burden of illness of IBS in the Netherlands is substantial. IBS patients treated with mebeverine experienced low quality of life and suffered from severe pain. Based on these results, more attention for the diagnosis and treatment of IBS seems to be justified.

Overview

Integrity signals

Registry

Crossref · 10.1097/00042737-200605000-00004

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 24 references

Research works printed but not linked: 3

  1. Donker, 1999, Br J Gen Pract, 49, 787
  2. Janssen, 2000, Br J Gen Pract, 50, 375
  3. van der Horst, 2001, Geneesmiddelenbulletin, 36, 15

Cited by

See all 35

Metadata

Authors
ten Berg, M. J., Goettsch, W. G., van den Boom, G., Smout, A. J. P. M., & Herings, R. M. C.
Affiliations
  • Pharmo Institute (NL)
  • University Medical Center Utrecht (NL)
  • Utrecht University (NL)
Corresponding author
Goettsch, Wim G.
Venue
European Journal of Gastroenterology & Hepatology
Published
2006-05
Volume
18
Issue
5
Pages
475-481
ISSN
0954-691X (ISSN-L)
OpenAlex
W1992494082
Cited by
35
References
24
Citations by year
2026: 1 · 2024: 1 · 2023: 2 · 2022: 2 · 2021: 1 · 2019: 1 · 2018: 2 · 2017: 1 · 2016: 2 · 2015: 1 · 2014: 2 · 2013: 4 · 2012: 2
FWCI
3.06
Type
journal article
Language
en
Open access
closed
Locations
  • European Journal of Gastroenterology & Hepatology (publishedVersion)
  • PubMed (publishedVersion)
  • Pure Amsterdam UMC (publishedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
Topics
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
  • Health Sciences › Medicine › Epidemiology › Chronic Disease Management Strategies
Keywords
irritable bowel syndrome, quality of life, disease burden, mebeverine, abdominal pain, health status, productivity loss, Rome II criteria, community pharmacy patients, EQ-5D, SF-6D
MeSH terms
Chronic Disease, Constipation, Diarrhea, Female, Health Status, Health Surveys, Humans, Male, Middle Aged, Parasympatholytics, Phenethylamines, Quality of Life, Surveys and Questionnaires, Abdominal Pain, Cost of Illness, Irritable Bowel Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Quality of life of patients with irritable bowel syndrome is low compared to others with chronic diseases. https://app.cochat.ai/papers/10.1097/00042737-200605000-00004
The paper
ten Berg, M. J., Goettsch, W. G., van den Boom, G., Smout, A. J. P. M., & Herings, R. M. C. (2006). Quality of life of patients with irritable bowel syndrome is low compared to others with chronic diseases. European Journal of Gastroenterology & Hepatology. https://doi.org/10.1097/00042737-200605000-00004

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.